Sec Form 4 Filing - ADVENT INTERNATIONAL CORP/MA @ Syneos Health, Inc. - 2020-09-17

Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
ADVENT INTERNATIONAL CORP/MA
2. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc. [ SYNH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
PRUDENTIAL TOWER, 800 BOYLSTON STREET, SUITE 3300
3. Date of Earliest Transaction (MM/DD/YY)
09/17/2020
(Street)
BOSTON, MA02199-8069
4. If Amendment, Date Original Filed (MM/DD/YY)
09/21/2020
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/17/2020S( 1 ) 3,766,281 ( 1 ) D $ 59.26 18,647,036 ( 2 ) I See Notes ( 3 ) ( 4 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
ADVENT INTERNATIONAL CORP/MA
PRUDENTIAL TOWER, 800 BOYLSTON STREET
SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII 2014 Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII-A 2014 Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII Cayman Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII 2014 Cayman Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII-B Cayman Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII-A Cayman Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII-A Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA02199-8069
X
Signatures
See Exhibit 99.209/22/2020
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )See Exhibit 99.1 for text of footnote (1).
( 2 )See Exhibit 99.1 for text of footnote (2).
( 3 )See Exhibit 99.1 for text of footnote (3).
( 4 )See Exhibit 99.1 for text of footnote (4).

Remarks:
Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Amendment to Form 4 (this "Form 4/A") is being filed solely to correct certain errors in the text of the footnotes of the original Form 4 filing. This Form 4/A is the third of six Form 4/As being filed relating to the same event. This Form 4/A has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.